NO993738L - 2-amino-substituerte pyridiner som kan anvendes ved behandling ved arteriosclerose og hyper-lipoproteinemi - Google Patents

2-amino-substituerte pyridiner som kan anvendes ved behandling ved arteriosclerose og hyper-lipoproteinemi

Info

Publication number
NO993738L
NO993738L NO993738A NO993738A NO993738L NO 993738 L NO993738 L NO 993738L NO 993738 A NO993738 A NO 993738A NO 993738 A NO993738 A NO 993738A NO 993738 L NO993738 L NO 993738L
Authority
NO
Norway
Prior art keywords
amino
substituted pyridines
arteriosclerosis
treatment
lipoproteinemia
Prior art date
Application number
NO993738A
Other languages
English (en)
Norwegian (no)
Other versions
NO993738D0 (no
Inventor
Carsten Schmeck
Arndt Brandes
Michael Loegers
Gunter Schmidt
Klaus-Dieter Bremm
Hilmar Bischoff
Delf Schmidt
Joachim Schuhmacher
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of NO993738D0 publication Critical patent/NO993738D0/no
Publication of NO993738L publication Critical patent/NO993738L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/74Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
NO993738A 1997-02-05 1999-08-02 2-amino-substituerte pyridiner som kan anvendes ved behandling ved arteriosclerose og hyper-lipoproteinemi NO993738L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19704243A DE19704243A1 (de) 1997-02-05 1997-02-05 Neue 2-Amino-substituierte Pyridine
PCT/EP1998/000362 WO1998034920A1 (de) 1997-02-05 1998-01-23 2-amino-substituierte pyridine verwendbar zur behandlung von arteriosklerose und hyperlipoproteinemie

Publications (2)

Publication Number Publication Date
NO993738D0 NO993738D0 (no) 1999-08-02
NO993738L true NO993738L (no) 1999-09-17

Family

ID=7819326

Family Applications (1)

Application Number Title Priority Date Filing Date
NO993738A NO993738L (no) 1997-02-05 1999-08-02 2-amino-substituerte pyridiner som kan anvendes ved behandling ved arteriosclerose og hyper-lipoproteinemi

Country Status (19)

Country Link
EP (1) EP0973744A1 (de)
JP (1) JP2001510478A (de)
KR (1) KR20000070756A (de)
CN (1) CN1252057A (de)
AU (1) AU730109B2 (de)
BG (1) BG103631A (de)
BR (1) BR9807181A (de)
CA (1) CA2279636A1 (de)
CZ (1) CZ279299A3 (de)
DE (1) DE19704243A1 (de)
HU (1) HUP0001022A2 (de)
ID (1) ID24208A (de)
IL (1) IL131127A0 (de)
NO (1) NO993738L (de)
NZ (1) NZ337011A (de)
PL (1) PL334899A1 (de)
SK (1) SK104099A3 (de)
TR (1) TR199901857T2 (de)
WO (1) WO1998034920A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19845402B4 (de) * 1998-10-02 2005-04-07 Aventis Pharma Deutschland Gmbh Mit Heterocyclen substituierte Propanolaminderivate, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung
OA12625A (en) 2001-06-22 2006-06-12 Pfizer Prod Inc Pharmaceutical compositions of adsorbates of amorphous drug.
JP2004534812A (ja) 2001-06-22 2004-11-18 ファイザー・プロダクツ・インク 薬物および中性ポリマーの分散物の医薬組成物
DE60320940D1 (de) 2002-02-01 2008-06-26 Pfizer Prod Inc Pharmazeutische zusammensetzungen amorpher dispersionen von wirkstoffen und lipophiler mikrophasenbildender materialien
WO2004082675A1 (en) 2003-03-17 2004-09-30 Japan Tobacco Inc. Method for increasing the oral bioavailability of s-[2- ([[1- (2-ethylbutyl) cyclohexyl] carbonyl] amino) phenyl] 2-methylpropanethioate
CL2004001884A1 (es) 2003-08-04 2005-06-03 Pfizer Prod Inc Procedimiento de secado por pulverizacion para la formacion de dispersiones solidas amorfas de un farmaco y polimeros.
BRPI0413277A (pt) 2003-08-04 2006-10-10 Pfizer Prod Inc composições farmacêuticas de adsorvatos de medicamentos amorfos e materiais que formam microfases lipofìlicas
MXPA06003357A (es) 2003-09-26 2006-06-08 Japan Tobacco Inc Metodo para inhibir la produccion de lipoproteina remanente.
DOP2005000123A (es) * 2004-07-02 2011-07-15 Merck Sharp & Dohme Inhibidores de cetp
WO2006032987A1 (en) * 2004-09-23 2006-03-30 Pfizer Products Inc. Indoline compounds and their use in the treatment of arteriosclerosis
WO2006082518A1 (en) 2005-02-03 2006-08-10 Pfizer Products Inc. Pharmaceutical compositions with enhanced performance
US20100113473A1 (en) 2008-10-30 2010-05-06 Player Mark R Aryl amide compound as an acetyl coenzyme a carboxylase inhibitor

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5169857A (en) * 1988-01-20 1992-12-08 Bayer Aktiengesellschaft 7-(polysubstituted pyridyl)-hept-6-endates useful for treating hyperproteinaemia, lipoproteinaemia or arteriosclerosis

Also Published As

Publication number Publication date
CZ279299A3 (cs) 1999-11-17
SK104099A3 (en) 2000-01-18
JP2001510478A (ja) 2001-07-31
BG103631A (en) 2000-11-30
IL131127A0 (en) 2001-01-28
AU6212398A (en) 1998-08-26
HUP0001022A2 (hu) 2000-09-28
AU730109B2 (en) 2001-02-22
PL334899A1 (en) 2000-03-27
CN1252057A (zh) 2000-05-03
EP0973744A1 (de) 2000-01-26
TR199901857T2 (xx) 1999-10-21
NO993738D0 (no) 1999-08-02
ID24208A (id) 2000-07-13
KR20000070756A (ko) 2000-11-25
CA2279636A1 (en) 1998-08-13
NZ337011A (en) 2001-04-27
BR9807181A (pt) 2000-01-25
DE19704243A1 (de) 1998-08-06
WO1998034920A1 (de) 1998-08-13

Similar Documents

Publication Publication Date Title
NO993738L (no) 2-amino-substituerte pyridiner som kan anvendes ved behandling ved arteriosclerose og hyper-lipoproteinemi
NO971269L (no) 2-aryl-substituerte pyridiner
GEP20032922B (en) Benzoheterocycles and Their Use as MEK Inhibitors
NO20062130L (no) 4-(pyrazol-3-ylamino)pyrimidinderivater for anvendelse i behandling av kreft
ATE301460T1 (de) Zubereitung zur prophylaxe oder behandlung der demenz-erkrankung enthaltend ein hydroxyzimtsäurederivat oder einen extrakt einer pflanze der gattung angelica, der diese säure enthält.
NO20074773L (no) Caspaseinhibitorer og anvendelse derav
NO983003L (no) Vitronectin-reseptor-antagonister
DE69919334D1 (de) Phenylalaninderivate als inhibitoren von alpha4 integrinen
MY112413A (en) Substituted heterocyclic carboxamides, their preparation and their use as pharmaceuticals
ATE339406T1 (de) Chinazoline verbindungen als heilmittel
GEP20032869B (en) Alpha -Ketoamide Inhibitors of 20S Proteasome, Pharmaceutical Preparations Containing the Same and Methods for Treatment
AU7779900A (en) Trifluoromethyl-substituted spirocyclic ketoenols
ATE191218T1 (de) Rapamycin-derivate als immunosuppressoren
RU94044677A (ru) Трехзамещенные фенильные производные, способ получения, фармацевтическая композиция
NO20030301L (no) Nye heteroarylderivater og anvendelse derav som farmasöytika
ATE260910T1 (de) 4-heteroaryl-tetrahydrochinoline und ihre verwendung als inhibitoren des cholesterin-ester- transfer-proteins (ctep)
AU5377698A (en) Substituted pyrrolyl compounds for the treatment of inflammation
NO20013680L (no) Ketolidantibiotika
WO1998042659A3 (en) Aryl- or heteroarylsulfonamide substituted hydroxamic acid derivates, process for their preparation and their use as pharmaceuticals
WO1992019617A3 (en) Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use
GEP20002187B (en) Carboxamide Derivatives of Pyrrolidine, Piperidine and Hexahydroazepine, Composition for the Treatment of Thrombosis Disorders Induced by Thrombocytes, Intermediate Compounds and Method for Their Preparation
ATE267187T1 (de) Als entzündungshemmende mittel nützliche dihydrobenzofurane und verwandte verbindungen
DE69719358D1 (de) Substituierte dihydrobenzofurane als pde-hemmstoffe
ATE303384T1 (de) 1-biaryl-1,8-naphthyridin-4-one als phosphodieseterase-inhibitoren
DE69927584D1 (de) Pharmazeutische zubereitungen zur behandlung von magengeschwüren

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application